Summary
In 13,799 UK adults at higher risk from respiratory infections, advice to use a gel-based or a saline nasal spray at the first sign of illness shortened days of illness compared with usual care, and all three interventions reduced antibiotic use. The gel spray caused more headache and sinus pain, and the behavioral website did not shorten illness.
Key points
- Over 6 months, people given usual care had a mean of 8.2 days of illness, compared with 6.5 days with the gel-based spray and 6.4 days with the saline spray.
- The website promoting physical activity and stress management did not reduce days of illness (7.4 days).
- Antibiotic use was lower with all three interventions than with usual care.
- Headache or sinus pain was more common with the gel-based spray (7.8%, against 4.8% with usual care).
- Design: randomized, open-label trial at 332 UK general practices in 13,799 adults at higher risk from respiratory infections.
- Funding: National Institute for Health and Care Research (NIHR).
